GlassScriptPhysician profile
Joseph Fred Bender
NPI 1265436828
$2,241.00
in general payments reported to CMS, 2019-2025
15 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $738 · 2020: $148 · 2021: $297 · 2022: $559 · 2023: $60.41 · 2024: $27.64 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $778.89 | 2019-2025 | Grafix Pl, Collagenase Santyl, Oasis |
| Organogenesis INC. | $752.53 | 2019-2025 | Apligraf, Cygnus Matrix, Via Matrix |
| Osiris Therapeutics INC. | $209.66 | 2019 | |
| Horizon Therapeutics Plc | $133.07 | 2019-2021 | |
| Melinta Therapeutics, LLC | $59.35 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $51.55 | 2025 | Nuzyra |
| Hydrofera LLC | $47.67 | 2022 | |
| Bioventus LLC | $39.65 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Aroa Biosurgery Incorporated | $35.89 | 2020-2025 | |
| Next Science LLC | $30.06 | 2023 | Surgx, Blastx, Xperience |
| Intuitive Surgical, INC. | $23.33 | 2019 | |
| Grt US Holding, INC. | $22.22 | 2022 | |
| Amniox Medical, INC. | $20.71 | 2020 | |
| Tactile Systems Technology INC | $19.94 | 2020 | |
| Kerecis Limited | $16.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.